About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Unrelated Donor Stem Cell Transplantation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01364363

Unrelated Donor Stem Cell Transplantation

The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cel...

Lead sponsor: Scripps Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Scripps Health

same

Age

18 - 69 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\> 18 years of Age
•\< 70 years
•ECOG performance status 0, 1 or 2
•Left Ventricular Ejection Fraction \> 30%
•Creatinine clearance \> 40ml/min
•Transaminases \< 2X normal
•Total bilirubin \< 2X normal
•HIV seronegativity
•Weight \< 70kg for cord blood transplantation
•Ability to cover the cost of the transplant, necessary medications, and transportation/housing.
•Caregiver must be available while outpatient

Exclusion Criteria

•Greater than one antigen mismatch at HLA-A, B, C or DR plus one allele mismatch at HLA-A, B, C or DR

Related studies

RECRUITINGPhase 2

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

NCT03520647 · Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), and more

Natural History of Acquired and Inherited Bone Marrow Failure Syndromes

NCT05012111 · Severe Aplastic Anemia, Telomere Biology Disorders, and more

RECRUITINGPhase 1/2

Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

NCT05876312 · Paroxysmal Nocturnal Hemoglobinuria (PNH)

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more

RECRUITINGPhase 1

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NCT06656494 · Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 23, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment64

Start dateMar 2005

Last updatedNov 23, 2022

Condition

Severe Aplastic Anemia Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes+8 more

Locations shown

Scripps Green Hospital

La Jolla, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 23, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions